
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT is expected to see strong growth in its revenue per available day (RevPAR) in 2026 and 2027 due to the stable operating performance of its Integrated Senior Health Campus/Trilogy and SHOP segments. This growth is also supported by the company's investment accretion and moderating interest expense. Despite regulatory risks and concerns about its largest tenant/operator, Trilogy, AHR's strong market position and competitive advantage in the healthcare real estate space make it a favorable investment with an attractive earnings growth outlook.
Bears say
American Healthcare REIT is facing significant risks from several areas, including tenant risk, development and redevelopment risk, and interest rate risk. Furthermore, the company is highly dependent on its Trilogy segment, which contributes to the majority of its revenue. The unpredictable nature of the healthcare industry, labor availability risks, and potential changes in regulations could also adversely affect the company's operations. Additionally, there are concerns about the company's ability to sustain its dividend and manage its cost of capital, and investors should carefully consider these risks before investing in the company's stock.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares